On March 19, 2020, California Gov. Gavin Newsom announced statewide requirements in light of the COVID-19 pandemic. These required actions in this order align with the Santa Clara County shelter-in-place orders released earlier this week and have not imposed any additional restrictions on Antibody Solutions operations. We will continue to monitor this situation and provide updates, as necessary.
On March 16, 2020, the Public Health Department of Santa Clara County, California, along with five other San Francisco Bay Area counties, issued a shelter-in-place order for all county residents in response to the COVID-19 pandemic. That includes us here at Antibody Solutions.
It is important to note that Antibody Solutions, as a biotechnology company, is exempt from the current shelter-in-place order for Santa Clara County. However, we are also prioritizing our employees’ safety. Rest assured, individuals essential to completing research campaigns will continue working in our headquarters facility in Santa Clara for the foreseeable future. Meanwhile, staff that can work remotely will be provided all the resources necessary to continue working from home during the shelter-in-place order. Additionally, we have implemented new health and safety practices and directed our staff to adhere to social distancing requirements in the order.
As we update our business continuity plan in light of COVID-19, we are closely monitoring this evolving situation and any potential impact on our operations. We’re striving to ensure that all of our ongoing projects can and do progress. We are working with our suppliers to ensure that we have the necessary materials to complete your projects. At this point, thankfully, we have not seen a significant impact on our supply chain.
If you have questions, please reach out to your project manager directly or simply call our main line at +1 (650) 938-4300 and use the automated phone tree. During this time, your call will be automatically routed to the mobile phone of the employee you selected.
Thank you for your understanding during these unusual and trying times. We’re grateful to have you as part of the Antibody Solutions family, and we appreciate your continued confidence.
We hope you and your family, friends and colleagues stay safe in the midst of this unprecedented situation, and we join you in looking forward to the day when COVID-19 will be a distant memory.
Author of more than 40 publications, John’s current research interests include new technologies for improving therapeutic antibody discovery, properties of next-generation antibody-like molecules, and best practices for critical reagents used in biologics development.